Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4390264 | 0.98 | POLB (0.41) | TLR8POLBPTGS2PTGS1RIPK1 | |
| SCHEMBL4393940 | 0.85 | LMNA (0.32) | TLR8POLB | |
| SCHEMBL4386364 | 0.83 | TLR8 (0.33) | TLR8POLB | |
| SCHEMBL4396360 | 0.79 | TLR8 (0.31) | TLR8 | |
| SCHEMBL4393956 | 0.79 | TLR8 (0.31) | TLR8 | |
| SCHEMBL4386118 | 0.72 | TLR8 (0.34) | TLR8PTGS2PTGS1 | |
| SCHEMBL14368387 | 0.72 | DPP4 (0.43) | POLB | |
| SCHEMBL4389192 | 0.70 | GHSR (0.32) | — | |
| SCHEMBL14368389 | 0.70 | DPP4 (0.44) | POLB | |
| SCHEMBL23964565 | 0.68 | POLB (0.35) | POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1569922-B1 | 1,2,4-THIADIAZOLE COMPOUNDS AND ARTHROPOD CONTROLLING COMPOSITION CONTAINING THE SAME | SUMITOMO CHEMICAL CO (JP) | 2009-12-02 | — | — | EP | disclosed |
| US-7301032-B2 | 1,2,4-thiadiazole compounds and arthropod controlling composition containing the same | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2007-11-27 | — | — | US | disclosed |
| US-20060052422-A1 | 1,2,4-Thiadiazole compounds and arthropod controlling composition containing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-03-09 | — | — | US | disclosed |
| EP-1569922-A1 | 1,2,4-THIADIAZOLE COMPOUNDS AND ARTHROPOD CONTROLLING COMPOSITION CONTAINING THE SAME | Sumitomo Chemical Company, Limited (JP) | 2005-09-07 | — | — | EP | disclosed |
| WO-2004046125-A1 | 1,2,4-THIADIAZOLE COMPOUNDS AND ARTHROPOD CONTROLLING COMPOSITION CONTAINING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2004-06-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060052422-A1 | 1,2,4-Thiadiazole compounds and arthropod controlling composition containing the same | NAT1, C1S, C1R | TLR8 4333/4885POLB 4831/4885PTGS2 3543/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.